Meta fends off trademark lawsuit from tech staffing company Metabyte
U.S. District Judge Vince Chhabria said on Friday, opens new tab that Metabyte could not show Meta's name would mislead consumers into thinking the two companies were affiliated, and that the case was "not a close call."
Metabyte CEO Manu Mehta said that the ruling "risks setting a troubling precedent that disadvantages smaller brand owners" and the company is reviewing its appeal options. An attorney and spokespeople for Meta did not immediately respond to a request for comment on Monday.
Metabyte is one of several companies that sued Meta Platforms for trademark infringement following its 2021 rebrand from Facebook. Fremont, California-based Metabyte said in its 2023 lawsuit that Meta Platforms' name would confuse consumers, arguing that the two companies offer related services and cover overlapping geographic areas.
Metabyte also asked the court to cancel the tech giant's "Meta" trademark because the term was generic.
Chhabria ruled for Meta on Friday and said Metabyte had "presented virtually no evidence of confusion on the part of prospective employees, and no evidence at all that any such confusion had any effect on Metabyte's business." He also affirmed the validity of Meta's trademark.
The case is Metabyte Inc v. Meta Platforms Inc, U.S. District Court for the Northern District of California, No. 3:23-cv-04862.
For Metabyte: Karthik Murthy of Murthy Patent Law
For Meta: Bobby Ghajar and Judd Lauter of Cooley
Read more:
Meta Platforms hit with US trademark lawsuit from tech company Metabyte
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Reuters
26 minutes ago
- Reuters
Trump administration in talks to take 10% stake in Intel, Bloomberg News reports
Aug 18 (Reuters) - The Trump administration is in talks to take a 10% stake in Intel by converting some or all of the struggling company's Chips Act grants into equity, Bloomberg News reported, citing a White House official and other people familiar with the matter. Shares of Intel (INTC.O), opens new tab fell about 3% on Monday, after rallying last week on hopes of U.S. federal support. A 10% stake in the American chipmaker would be worth about $10 billion. Intel has been slated to receive a combined $10.9 billion in Chips Act grants for commercial and military production, and the figure is roughly enough to pay for the government's holding, according to the Bloomberg report on Monday. Intel declined to comment on the report, while the White House did not respond to a request for comment. Reuters could not immediately verify the report. Media reports said last week that the U.S. government may buy a stake in Intel, after a meeting between CEO Lip-Bu Tan and President Donald Trump that was sparked by Trump's demand for the new Intel chief's resignation over his ties to Chinese firms. Federal backing could give Intel more breathing room to revive its loss-making foundry business, analysts have said, but it still suffers from a weak product roadmap and challenges in attracting customers to its new factories. "The fact that the U.S. government is stepping in to save a blue-chip American company likely means that Intel's competitive position was much worse than what anybody feared," said David Wagner, head of equity and portfolio manager at Intel shareholder Aptus Capital Advisors. Wagner added that while he was skeptical about the U.S. government investing taxpayer money into U.S. companies, it was better than having Intel become a state-owned entity. Aptus Capital Advisors holds 80,581 shares of Intel. Trump, who said the meeting with Tan was "very interesting" one, has taken an unprecedented approach to corporate interventions. He has pushed for multibillion-dollar government tie-ups in semiconductors and rare earths, such as a pay-for-play deal with Nvidia (NVDA.O), opens new tab and an arrangement with rare earth producer MP Materials (MP.N), opens new tab to secure critical minerals. The U.S. government has previously taken equity stakes in companies under stress. During the 2007-2009 financial crisis, it took a stake in General Motors (GM.N), opens new tab — later exiting the stake in 2013. Intel last year secured nearly $8 billion in subsidies, the largest outlay under the act, to build new factories in Ohio and other states as former CEO Pat Gelsinger bet on them to restore the company's manufacturing edge. Tan, however, pared back such ambitions, slowing construction in Ohio. He plans to build factories based on demand for the services, which analysts have said could put him at odds with Trump's push to shore up American manufacturing.
Reuters
44 minutes ago
- Reuters
Gold prices steady as investors assess Trump–Zelenskiy meeting
Aug 18 (Reuters) - Gold prices were largely steady on Monday, as investors focused on U.S. President Donald Trump's meeting with Ukrainian and European leaders, and the Federal Reserve's annual symposium in Jackson Hole this week. Spot gold was marginally down at $3,333.32 per ounce at 01:42 p.m. ET (1742 GMT), after hitting its lowest level since August 1 earlier in the session. U.S. gold futures for December delivery settled 0.1% lower at $3,378. The U.S. dollar gained 0.3%, making greenback-priced bullion more expensive for other currency holders. Trump said the U.S. would "help out" Europe in providing security for Ukraine as part of any deal to end Russia's war in Ukraine, as he and President Volodymyr Zelenskiy began a hastily arranged White House meeting to discuss a path to peace. The European leaders will meet with Trump afterwards in the White House's East Room at 3 p.m. EDT (1900 GMT), according to the White House. The meeting between Trump and Zelenskiy follows Trump's meeting with Putin on Friday, where the two leaders agreed to pursue a peace deal without implementing a ceasefire. "There was not much reaction in gold to the Putin-Trump meeting. I think we'll continue in this price range. The next inflection point is the Federal Reserve (conference)," said Marex analyst Edward Meir. Minutes from the U.S. central bank's July policy meeting are due on Wednesday, ahead of the Fed's annual conference in Jackson Hole, Wyoming, scheduled for August 21–23. Fed Chair Jerome Powell is expected to speak at the event. Investors will be watching out for Powell's remarks on the economic outlook. While markets have already priced in a 25 basis point cut, there's an outside chance of a 50 basis point reduction, which could drive gold prices higher, Meir said. Gold tends to perform strongly in environments with low interest rates and heightened uncertainty. Elsewhere, spot silver rose 0.1% at $38.02 per ounce, while platinum fell 0.1% to $1,334.10. Spot palladium gained 1% to $1,122.86 after falling to its lowest level since July 10 earlier in the session.
Reuters
an hour ago
- Reuters
CVS cannot obtain AIG, Chubb opioid coverage, top Delaware court rules
Aug 18 (Reuters) - CVS Health (CVS.N), opens new tab is not entitled to coverage from insurers, including AIG (AIG.N), opens new tab and Chubb , against thousands of lawsuits over its role in the nation's opioid crisis, Delaware's highest court ruled on Monday. The Delaware Supreme Court concluded that governments, hospitals, doctors and benefit plans that sued CVS sought damages for economic losses, not individualized "bodily injury" or "property damage" covered by CVS' general liability policies. It also rejected the argument that CVS' $5 billion nationwide settlement of opioid claims in November 2022 showed that the pharmacy chain and benefits manager had been sued for bodily injury. "The national settlement agreement funds expenses in response to the opioid crisis at-large, but it does not change the fact that the underlying lawsuits do not seek specific damages tied to individualized injuries," Chief Justice Collins Seitz wrote for a unanimous court. Neither CVS nor its lawyers immediately responded to requests for comment. AIG, Chubb and their lawyers did not immediately respond to similar requests. Many insurers have been sued by pharmacy chains, drugmakers and others seeking coverage for opioid-related bills. Chains had long argued they were merely filling doctors' prescriptions, but critics said the large quantities being dispensed and the potential for diversion were red flags. Walgreens (WBA.O), opens new tab and Walmart, opens new tab(WMT.N), opens new tab agreed to pay more than $8 billion in similar settlements. CVS, based in Woonsocket, Rhode Island, had been appealing two Delaware Superior Court decisions denying insurance coverage in more than 2,300 lawsuits, according to Monday's decision. Governments complained about increased spending to treat opioid addiction, hospitals reported strains on their health systems, and third-party payors such as employee benefit funds cited costs of prescription purchases and addiction treatment. The Delaware Supreme Court ruled in Chubb's favor in a similar case involving Rite Aid in 2022. CVS claimed that its own policies offered broader coverage, but the court found the policies "similar in all material respects" to Rite Aid's. The case is In re CVS Opioid Insurance Litigation, Delaware Supreme Court, No. 482.
